| Name | Title | Contact Details |
|---|
Propeller is the leading digital platform for respiratory health management.Through sensors, mobile apps and services, Propeller helps reduce the cost of care while delivering better quality of life for individuals with chronic respiratory disease. Backed by Safeguard Scientifics, Social Capital, California HealthCare Foundation and other investors, Propeller Health is now working with organizations like Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida and the City of Louisville. Company recognition includes TEDMED Innovation Showcase, White House Champion of Change and Bluetooth Breakthrough Product awards. The system has been featured in The Economist, Washington Post, Fast Company, Wired and Scientific American.
Located in northern California, Consensus Orthopedics is committed to providing proven and reliable total joint implants and instruments to the global market. Consensus headquarters include administrative offices, research and design workrooms, manufacturing, inspection, clean room and warehouse space. With over 25 years of orthopedic design and manufacturing experience, together, through a focus on patient care and clinician relationships, Consensus is dedicated to creating one team, focused on restoring mobility and renewing lives.
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.
PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo`s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.
Posey Company is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.